Clinical trialHuman

Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog

The Journal of clinical endocrinology and metabolism, 2006 Dec. Ionescu M, Frohman LA.

Study type

Clinical trial

Subjects

Human participants (PubMed MeSH: Humans)

Journal

The Journal of clinical endocrinology and metabolism

Published

2006 Dec

PubMed

PMID 17018654 ↗

DOI

10.1210/jc.2006-1702 ↗

Where PepCue cites this

This paper is part of the evidence base behind these profiles. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

CJC-1295 DAC →Mod-GRF (1-29) →peptides and trt stacking bloodwork →

Indexed under

MeSH terms assigned by the National Library of Medicine.

AdultGrowth HormoneGrowth Hormone-Releasing HormoneHumansInjectionsInsulin-Like Growth Factor IMalePeptide FragmentsPulsatile Flow

Other papers on CJC-1295 DAC

Randomized controlled trial · 2006

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults

Journal article · 2006

Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page